Positioning itself very much at the forefront of the new economy space, the ‘technically strong’ team at Sidley Austin delivers ’high-quality work’ for an issuer-focused client base seeking to list on the HKEX. The team has been at the vanguard of the new listing rules affecting both pre-revenue healthcare and specialist tech companies, having had a key role in actually shaping the 18C listing rules through its interactions with the regulator. The ‘very commercial’ Claudia Yu, who is ’particularly capable at advising on novel rules and pioneer transactions’, has been key to much of this work, including her lead role for QuantumPharm Inc., in what is the first specialist technology company expected to list under the new Chapter 18C. Himself a former scientist, Meng Ding has deep industry understanding and is also key to much of this work, excelling in drafting the underlying prospectuses. The ‘technical, commercial and responsive’ Sherlyn Lau is also key to the firm’s growing success and co-heads team alongside Constance Choy.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'The team consistently delivers high-quality work.'
  • 'This technically strong team stands out as having the experience and ability in handling complex structures and is able to offer solutions for novel and common issues alike.'
  • 'Sherlyn Lau is technical, commercial and responsive. Great problem solver.'
  • 'The very commercial Claudia Yu acts as a good conduit between the issuers and the regulators. She is particularly capable of advising on novel rules and pioneer transactions.'
  • 'Claudia Yu is very knowledgeable about HK listing rules and other regulations She has strong access to both HKEX and the SFC vetting team she always stands by to help address challenging questions.'

Key clients

  • BaTeLab Co., Ltd.
  • Qyuns Therapeutics Co., Ltd.
  • QuantumPharm Inc.
  • CITIC Securities (Hong Kong) Limited
  • Mobile-health Networks Solutions
  • ICBC International Capital Limited
  • LC Logistics, Inc.
  • China International Capital Corporation Hong Kong Securities Limited
  • China Securities (International) Corporate Finance Company Limited
  • Ryde Group Ltd
  • Haitong International Capital Limited
  • Huatai Financial Holdings (Hong Kong) Limited
  • Bitdeer Technologies Holding Company
  • MicroPort Cardiac Rhythm Management Limited
  • Noco-Noco Pte. Ltd.
  • China Merchants Securities (HK) Co., Limited
  • Shenzhen IVF Hospital Management Group Co., Ltd.
  • Gala Technology Holding Limited
  • US Tiger Securities, Inc.

Work highlights

  • Advising QuantumPharm Inc. in connection with the proposed IPO on the Main Board of the HKEX.
  • Advised BaTeLab Co. in its IPO and H share listing on the Main Board of the HKEX.
  • Advised Qyuns Therapeutics Co. on its IPO and H shares listing on the Main Board of the HKEX under Chapter 18A of the Listing Rules.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Constance Choy, Sherlyn Lau

Other key lawyers

Meng Ding, Claudia Yu